Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Bordet

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|June 8, 2019
Ocular gene therapies in clinical practice: viral vectors and nonviral alternativesThierry Bordet, Francine Behar-Cohen
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2009
Targeting neuroprotection as an alternative approach to preventing and treating neuropathic painThierry Bordet, Rebecca M Pruss
International Ophthalmology Clinics|September 29, 2021
Gene Therapy for UveitisRonald R Buggage, Thierry Bordet
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective CompoundThierry Bordet, Patrick Berna, Jean-Louis Abitbol, et al.
Biochemical Pharmacology|April 27, 2010
Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cellsAmandine Rovini, Manon Carré, Thierry Bordet, et al.
Neuroreport|August 2, 2002
Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochleaMao Li Duan, Thierry Bordet, Mauro Mezzina, et al.
Pain|October 17, 2009
Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxelWen Hua Xiao, Felix Y Zheng, Gary J Bennett, et al.
Gastroenterology|July 10, 2003
Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in ratsMatilde Bustos, Naiara Beraza, Juan-Jose Lasarte, et al.
Future Medicinal Chemistry|March 24, 2011
Drug discovery and development for spinal muscular atrophy: lessons from screening approaches and future challenges for clinical developmentRebecca M Pruss, Marc Giraudon-Paoli, Svetlana Morozova, et al.
Human Molecular Genetics|June 21, 2002
In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn miceJeanne-Claire Lesbordes, Thierry Bordet, Georg Haase, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|June 8, 2019
Ocular gene therapies in clinical practice: viral vectors and nonviral alternativesThierry Bordet, Francine Behar-Cohen
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 1, 2009
Targeting neuroprotection as an alternative approach to preventing and treating neuropathic painThierry Bordet, Rebecca M Pruss
International Ophthalmology Clinics|September 29, 2021
Gene Therapy for UveitisRonald R Buggage, Thierry Bordet
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective CompoundThierry Bordet, Patrick Berna, Jean-Louis Abitbol, et al.
Biochemical Pharmacology|April 27, 2010
Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cellsAmandine Rovini, Manon Carré, Thierry Bordet, et al.
Neuroreport|August 2, 2002
Adenoviral and adeno-associated viral vector mediated gene transfer in the guinea pig cochleaMao Li Duan, Thierry Bordet, Mauro Mezzina, et al.
Pain|October 17, 2009
Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxelWen Hua Xiao, Felix Y Zheng, Gary J Bennett, et al.
Gastroenterology|July 10, 2003
Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in ratsMatilde Bustos, Naiara Beraza, Juan-Jose Lasarte, et al.
Future Medicinal Chemistry|March 24, 2011
Drug discovery and development for spinal muscular atrophy: lessons from screening approaches and future challenges for clinical developmentRebecca M Pruss, Marc Giraudon-Paoli, Svetlana Morozova, et al.
Human Molecular Genetics|June 21, 2002
In vivo electrotransfer of the cardiotrophin-1 gene into skeletal muscle slows down progression of motor neuron degeneration in pmn miceJeanne-Claire Lesbordes, Thierry Bordet, Georg Haase, et al.
Pageof 3